From Name:
From Email:
To Name:
To Email:

Optional Message:


Why survival rate is not the best way to judge cancer spending

from The New York Times

In 2012, a study published in Health Affairs argued that the big money we spend on healthcare in the United States is worth it, at least when it comes to cancer. The researchers found that the survival gains seen in the United States equated to more than $550 billion in additional value, more than the difference in spending. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063